Literature DB >> 6778084

Recirculation in the acute period of cerebral infarction: experimental research on brain swelling and its suppression by using mannitol or glycerol.

J Suzuki, S Tanaka, T Yoshimoto, H Seki.   

Abstract

Using our previously published "incomplete cerebral hemispheric infarction model in dogs" (produced by simultaneous ipsilateral occlusions of the anterior cerebral artery at the branching of the ethmoidal artery from its A1 portion, the A2 portion, the internal carotid artery, the posterior communication artery, the posterior cerebral artery, and the anterior cerebellar artery), two, four, or six hours occlusion of blood flow was undertaken. Observations were then made on the degree of brain swelling following recirculation due to administration of mannitol or glycerol solutions. Furthermore, the leakage of Evans blue was investigated to determine the damage to the blood brain barrier. 1. In the animals given mannitol or glycerol, brain swelling was suppressed, following two hours occlusion, In the animals given mannitol, however, brain swelling was not suppressed after four or six hours occlusion. 2. After two hours occlusion in the animals given mannitol, leakage of Evans blue was slight compared with the untreated group. In the six hours occlusion groups, severe leakage of Evans blue was seen in both the untreated animals and the mannitol-treated. After two hours occlusion, in some animals which had been given glycerol, severe leakage of Evans blue was seen, even when there was little brain swelling.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778084     DOI: 10.1007/bf01407089

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  16 in total

1.  ORAL GLYCEROL FOR THE REDUCTION OF INTRACRANIAL PRESSURE.

Authors:  G CANTORE; B GUIDETTI; M VIRNO
Journal:  J Neurosurg       Date:  1964-04       Impact factor: 5.115

2.  The production of an acute haemolytic crisis by the subcutaneous injection of glycerol.

Authors:  G R CAMERON; E S FINCKH
Journal:  J Pathol Bacteriol       Date:  1956-01

3.  [Intracranial definitive aneurysm surgery under normothermia and normotension--utilizing temporary occlusion of major cerebral arteries and preoperative mannitol administration (author's transl)].

Authors:  T Yoshimoto; J Suzuki
Journal:  No Shinkei Geka       Date:  1976-08

4.  Effects of glycerol infusions on brain water and electrolytes.

Authors:  R Guisado; A I Arieff; S G Massry
Journal:  Am J Physiol       Date:  1974-10

5.  Energy metabolites and water content in rat brain during the early stage of development of cerebral infarction.

Authors:  K Kogure; R Busto; P Scheinberg; O M Reinmuth
Journal:  Brain       Date:  1974-03       Impact factor: 13.501

6.  Resuscitation of the monkey brain after 1 h complete ischemia. I. Physiological and morphological observations.

Authors:  K A Hossmann; V Zimmermann
Journal:  Brain Res       Date:  1974-11-29       Impact factor: 3.252

7.  Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema.

Authors:  H J Reulen; R Graham; M Spatz; I Klatzo
Journal:  J Neurosurg       Date:  1977-01       Impact factor: 5.115

8.  [Production of infarction model in dogs by several brain arteries occlusion. Part 1: Production of hemispheric non blood supply model (author's transl)].

Authors:  S Tanaka; T Yoshimoto; T Sakamoto; H Seki; J Suzuki
Journal:  No To Shinkei       Date:  1979-07

9.  Modification of acute focal ischemia by treatment with mannitol.

Authors:  J R Little
Journal:  Stroke       Date:  1978 Jan-Feb       Impact factor: 7.914

10.  Experimental cerebral infarction. Part 3: Protective effect of mannitol in thalamic infarction in dogs.

Authors:  T Yoshimoto; T Sakamoto; T Watanabe; S Tanaka; J Suzuki
Journal:  Stroke       Date:  1978 May-Jun       Impact factor: 7.914

View more
  1 in total

1.  Suppression of brain swelling with mannitol and perfluorochemicals. An experimental study.

Authors:  J Suzuki; S Tanaka; T Yoshimoto
Journal:  Acta Neurochir (Wien)       Date:  1981       Impact factor: 2.216

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.